New Haven biotech acquires drug candidate for severe anemia for $3 million
The drug candidate, RLYB331, is being developed to treat patients with severe anemia from...
Source: ctpost.com
Stay updated with breaking news from Allybio Corp . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drug candidate, RLYB331, is being developed to treat patients with severe anemia from...
The drug candidate, RLYB331, is being developed to treat patients with severe anemia from...